‘DURVIT’: a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node mi...

by J. Rotman, C. H. Mom, E. S. Jordanova, T. D. de Gruijl, G. G. Kenter
Published 2018-09-01

Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy

by Kim M. van Pul, Marieke F. Fransen, Rieneke van de Ven, Tanja D. de Gruijl
Published 2021-03-01

Comparative phenotypic and functional analysis of migratory dendritic cell subsets from human oral mucosa and skin.

by Ilona Jennifer Kosten, Rieneke van de Ven, Maria Thon, Susan Gibbs, Tanja D de Gruijl
Published 2017-01-01

Gingiva Equivalents Secrete Negligible Amounts of Key Chemokines Involved in Langerhans Cell Migration Compared to Skin Equivalents

by Ilona J. Kosten, Jeroen K. Buskermolen, Sander W. Spiekstra, Tanja D. de Gruijl, Susan Gibbs
Published 2015-01-01

Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma

by Amanda A. van Vliet, Anna-Maria Georgoudaki, Monica Raimo, Tanja D. de Gruijl, Jan Spanholtz
Published 2021-09-01

Transcriptional profiling of human dendritic cell populations and models--unique profiles of in vitro dendritic cells and implications on functionality and applicability.

by Kristina Lundberg, Ann-Sofie Albrekt, Inge Nelissen, Saskia Santegoets, Tanja D de Gruijl, Sue Gibbs, Malin Lindstedt
Published 2013-01-01

CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond

by Lisa A. King, Roeland Lameris, Tanja D. de Gruijl, Hans J. van der Vliet, Hans J. van der Vliet
Published 2018-07-01

Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond

by Lisa A. King, Roeland Lameris, Tanja D. de Gruijl, Hans J. van der Vliet, Hans J. van der Vliet
Published 2018-11-01

Hematopoietic Cancer Cell Lines Can Support Replication of Sabin Poliovirus Type 1

by Dinja Oosterhoff, Gerard van de Weerd, Gerco van Eikenhorst, Tanja D. de Gruijl, Leo A. van der Pol, Wilfried A. M. Bakker
Published 2015-01-01

Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression

by Dorian Stolk, Hans J. van der Vliet, Tanja D. de Gruijl, Yvette van Kooyk, Mark A. Exley, Mark A. Exley, Mark A. Exley
Published 2018-09-01

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments

by John P. Veluchamy, John P. Veluchamy, Nina Kok, Hans J. van der Vliet, Henk M. W. Verheul, Tanja D. de Gruijl, Jan Spanholtz
Published 2017-05-01

Human Bone Marrow-Derived Myeloid Dendritic Cells Show an Immature Transcriptional and Functional Profile Compared to Their Peripheral Blood Counterparts and Separate from Slan+ No...

by Nathalie van Leeuwen-Kerkhoff, Kristina Lundberg, Theresia M. Westers, Shahram Kordasti, Hetty J. Bontkes, Malin Lindstedt, Tanja D. de Gruijl, Arjan A. van de Loosdrecht
Published 2018-07-01

Defective Differentiation of Myeloid and Plasmacytoid Dendritic Cells in Advanced Cancer Patients is not Normalized by Tyrosine Kinase Inhibition of the Vascular Endothelial Growth...

by T. D. de Gruijl, G. Giaccone, R. J. Scheper, H. van Cruijsen, K. Hoekman, B. C. Kuenen, A. J. M. van den Eertwegh, A. G. M. Stam
Published 2007-01-01

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer.

by John Pradeep Veluchamy, Jan Spanholtz, Marleen Tordoir, Victor L Thijssen, Daniëlle A M Heideman, Henk M W Verheul, Tanja D de Gruijl, Hans J van der Vliet
Published 2016-01-01

Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma

by Renée Poels, Esther Drent, Roeland Lameris, Afroditi Katsarou, Maria Themeli, Hans J. van der Vliet, Tanja D. de Gruijl, Niels W.C.J. van de Donk, Tuna Mutis
Published 2021-01-01

Phenotypic and Functional Properties of Human Steady State CD14+ and CD1a+ Antigen Presenting Cells and Epidermal Langerhans Cells.

by Cynthia M Fehres, Sven C M Bruijns, Brigit N Sotthewes, Hakan Kalay, Lana Schaffer, Steven R Head, Tanja D de Gruijl, Juan J Garcia-Vallejo, Yvette van Kooyk
Published 2015-01-01

Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot study

by Elisa C. Toffoli, Maike G. Sweegers, Hetty J. Bontkes, Teatske M. Altenburg, Henk M.W. Verheul, Hans J. van derVliet, Tanja D. deGruijl, Laurien M. Buffart
Published 2021-06-01

Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response

by Elisa C. Toffoli, Abdolkarim Sheikhi, Yannick D. Höppner, Pita de Kok, Mahsa Yazdanpanah-Samani, Jan Spanholtz, Henk M. W. Verheul, Hans J. van der Vliet, Tanja D. de Gruijl
Published 2021-02-01

Expression of Oncolytic Adenovirus-Encoded RNAi Molecules Is Most Effective in a pri-miRNA Precursor Format

by Tereza Brachtlova, Jan-Willem van Ginkel, Mark J. Luinenburg, Renée X. de Menezes, Danijela Koppers-Lalic, D. Michiel Pegtel, Wenliang Dong, Tanja D. de Gruijl, Victor W. van Beusechem
Published 2020-12-01

Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8⁺ T Cell Responses via CD169⁺ Macrophages and cDC1

by Joanna Grabowska, Dorian A. Stolk, Maarten K. Nijen Twilhaar, Martino Ambrosini, Gert Storm, Hans J. van der Vliet, Tanja D. de Gruijl, Yvette van Kooyk, Joke M.M. den Haan
Published 2021-01-01